These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25261987)

  • 21. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
    Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
    Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma.
    Lin T; Ding YQ; Li JM
    Med Oncol; 2012 Jun; 29(2):878-85. PubMed ID: 21336986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.
    Kwon CH; Park HJ; Lee JR; Kim HK; Jeon TY; Jo HJ; Kim DH; Kim GH; Park DY
    Br J Cancer; 2014 Nov; 111(10):1993-2002. PubMed ID: 25211665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.
    Hou Z; Xie L; Yu L; Qian X; Liu B
    Med Oncol; 2012 Jun; 29(2):886-92. PubMed ID: 21347720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of prognostic significance of SOCS-1 expression in colorectal adenocarcinomas.
    Ayyildiz T; Dolar E; Adim SB; Eminler AT; Yerci O
    Asian Pac J Cancer Prev; 2014; 15(19):8469-74. PubMed ID: 25339048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The overexpression of AP-4 as a prognostic indicator for gastric carcinoma.
    Xinghua L; Bo Z; Yan G; Lei W; Changyao W; Qi L; Lin Y; Kaixiong T; Guobin W; Jianying C
    Med Oncol; 2012 Jun; 29(2):871-7. PubMed ID: 21336989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
    Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
    Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
    Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
    Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
    Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
    Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
    Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
    Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
    Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
    Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
    Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
    Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
    Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
    Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
    Yan P; Li YH; Tang ZJ; Shu X; Liu X
    Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.